Support research and initiatives for Fetal Therapy
The Fetal Institute, Specializing in the assessment, counseling and management of patients with high-risk pregnancies in Florida

Institute for Surgical Excellence Announces Eftichia Kontopoulos, M.D., Ph.D. Appointment to the Advisory Board of Directors

Surgical Excellence banner

WASHINGTONThe Institute for Surgical Excellence (ISE) today announced the appointment of Eftichia Kontopoulos, M.D., Ph.D., to its Advisory Board of Directors. ISE is a non-profit organization that convenes leading innovators, hospital executives, and surgeons to develop consistent, teachable and measurable surgical standards that directly improve patient outcomes.

 

Dr. Kontopoulos is an internationally recognized Fetal Surgeon. After completing a research fellowship at Harvard University, she conducted her residency in Obstetrics and Gynecology (Ob/Gyn) at the Robert Wood Johnson University of Medicine and Dentistry of New Jersey, she continued there with her fellowship in Maternal Fetal Medicine. Subsequently, she served in the Ob/Gyn and Maternal Fetal Medicine Department at the University of South Florida, where she received formal training in Fetal Surgery and Fetal Therapy. She is double boarded in Ob/Gyn and Maternal Fetal Medicine. Currently, Dr. Kontopoulos practices at The Fetal Institute Miami, which she co-founded in 2017 providing consulting and management of high-risk pregnancies through specialized treatments. 

 

“Dr. Kontopoulos will be an invaluable addition to the ISE Advisory Board of Directors as she will bring her shared vision of improving patient care and experience, and advancing surgical excellence,” said Dr. Martin Martino, ISE Executive Board Member and Gynecologic Oncologist.

 

“I am very honored to be part of the Advisory Board of the Institute for Surgical Excellence. Over the past twenty years, advancements in surgical techniques and technologies have provided the possibility of successful treatment of fetal conditions that previously were considered incurable. I am a firm believer that through solid research and proper surgical inventions, we can change the lives of our patients and their families. I am happy to share my vision with that of ISE.” said Dr. Eftichia Kontopoulos, M.D., Ph.D..

 

Together with her team, Dr. Kontopoulos has performed several pioneering surgeries and World’s first procedures. Dr. Kontopoulos has published chapters, books, and multiple peer-reviewed articles. Dr. Kontopoulos is a frequently invited speaker on Fetal Therapy, Fetal Surgery, and Advanced Endoscopic Surgical techniques in National and International meetings.

 

Robotic surgery is transforming the healthcare landscape. With precision and perfection, surgeons can challenge traditional operating procedures by reducing pain, risk, and recovery time.  Today, minimally invasive techniques are primarily used in gynecology, urology, thoracic, and cardiac surgery.  ISE looks ahead to an exciting year filled with surgical milestones. 

#  #  #

ISE is a 501(c)(3) public charity, whose mission is to create lasting solutions for complex healthcare problems related to emerging technologies, with the ultimate goal to improve patient care and outcomes. ISE utilizes a systems-based approach (collective impact model) to bring together key stakeholders from a variety of sectors to identify issues, set clearly defined goals, facilitate collaboration, determine and fill gaps, and better inform health care consumers. ISE is embarking on a series of transformational projects with respect to the role and standards of surgical technologies, with the first and current focus on Robotic Surgery.  As part of this project, ISE continues to manage and develop the Robotic Training Network (RTN) through participation with hospitals across the country, and research-focused engagement with the Fundamentals of Robotics Surgery (FRS). 

More from The Fetal Institute

We're here to help

Our group specializes in the assessment, counseling and management of patients with high-risk pregnancies in Florida.